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S P E C I A L I Z E D  A N T I G E N - P R E S E N T I N G  C E L L S  
Splen ic  D e n d r i t i c  Cells a n d  P e r i t o n e a l - E x u d a t e  Cells  
I n d u c e d  by  M y c o b a c t e r i a  A c t i v a t e  Ef fec to r  
T Cells T h a t  Are  Res i s t an t  to  Suppress ion*  
By J. S. BRITZ,~ P. W. ASKENASE, W. PTAK, R. M. STEINMAN,§ AND 
R. K. GERSHON 
From the Departments of Pathology and Medicine and the Howard Hughes Medical Institute at Yale 
University School of Medicine, New Haven, Connecticut 06510; The Institute of Microbiology, Copernicus 
Medical School, Cracow, Poland; and The Rockefeller University, New York 10021 
Topical  application of  picryl chloride (PCL), 1 the chemically reactive form of the 
tr initrophenyl (TNP) hapten, regularly induces a contact hypersensitivity reaction 
(CS) that  is of  the long-lived type (>3 wk) (1). However, when T N P  is coupled to 
cells in vitro and  these cells are used for immunizat ion,  three different immunological  
outcomes m a y  ensue depending on the route of  administration and the type o f  cell to 
which T N P  is coupled. One  outcome is the development of  specific immunological  
unresponsiveness (tolerance). This results when TNP-coupled  lymphocytes or mac- 
rophages (peritoneal-exudate cells, PEC) are injected intravenously and is probably  
a result of  the induction of  specific suppressor T cells (1-3). A second outcome is the 
development of  an evanescent form of  CS that  results when T N P - P E C  are adminis- 
tered under  conditions that avoid rapid activation of  the suppressor circuit. This can 
be done by pretreating recipient mice with a low dose of  cyclophosphamide or 
injecting the TNP-labeled cells subcutaneously so that the initial contact  of  antigen 
with the immune system takes place in the draining lymph nodes rather than in the 
spleen (1-3). 
A third outcome is the development of  a long-lived form of  CS, similar to that  
achieved by topical application of  PCL. This form of  immuni ty  also occurs when 
TNP-coupled  epidermal Langerhans cells are used for immunizat ion,  even when these 
cells are injected intravenously and no cyclophosphamide is used (1). In fact, T N P -  
coupled Langerhans cells induce CS when coadministered with an immunosuppressive 
inoculum of TNP-PEC.  This implies that antigen presentation on Langerhans cells, 
* Supported in part by grants from the U. S. Public Health Service; grants AI-12211, AI-11077, AI- 
10497, AI-13013, CA-08593, CA-16359, and CA-14216, from the National Institutes of Health; and grant 
05-042-N from the Polish-American Agreement. 
:~ Supported by training grant AI-07019 from the National Institutes of Health. Current address: 
Department of Physiological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 
21205. 
§ Established Investigator of the American Heart Association. 
i Abbreviations used in this paper." APC, antigen-presenting cell; CFA, complete Freund's adjuvant; CS, 
contact hypersensitivity reactions; DC, dendritic cells; HBSS, Hanks' balanced salt solution; IFA, incom- 
plete Freund's adjuvant; Mff, macrophage; PBS, phosphate-buffered saline; PCL, picryl chloride; PEC~ 
peritoneal-exudate cells; TNBS, trinitrobenzene sulfonic acid; TNP, trinitrophenyl. 
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both in their normal  anatomic  position (i.e., the skin) or when placed in a different 
anatomic site (i.e., the spleen), activate effector cells that  are relatively resistant to the 
T cell-mediated suppression induced by the TNP-PEC.  
To  better unders tand these findings we asked four relevant experimental questions: 
(a) Are there other  normally occurr ing antigen-presenting cells with characteristics 
similar to Langerhans  cells? (b) I f  so, can more stringent criteria be used to establish 
that  the sensitized cells induced by such antigen presentation are indeed resistant to 
suppression? (c) can active antigen-presenting cells (APC) be induced into an inflam- 
matory  exudate by environmental  agents? (d) if so, could the induction of  these cells 
explain the mode of  action of  certain adjuvants? To  approach  question a we used 
TNP-coupled  splenic dendritic cells (DC) as a source of  immunogen  because they 
represent an "endogenous" component  of  lymphoid  tissue that  always express large 
amounts  of  Ia and H-2D in the resting state (4), are extremely active as accessory cells 
(5), and present their own alloantigens in an especially immunogenic  way (4). These 
are attributes that  one would expect to find in specialized APC. Question b was 
approached in two ways: first by coimmunizing mice with a tolerogenic dose of  
trinitrobenzene sulfonic acid (TNBS), known to induce TNP-specific suppressor cells 
(6), and second by adoptive transfer of  cells immunized by intravenous injection of  
hapten-labeled APC into naive recipients whose inducible suppressor cell populat ion 
remains intact. Questions c and d were approached by compar ing  the immune  
response produced by TNP-coupled  PEC that had been induced by the potent  
adjuvant  complete Freund's  adjuvant  (CFA), with the response induced by similarly 
labeled PEC that had been induced with a less potent adjuvant  or an adjuvant  that 
leads to an "evanescent" or easily suppressible immune  responses such as incomplete 
Freund's  adjuvant  (IFA). 
We found that  the intravenous injection of  T N P - D C  and TNP-CFA-PEC,  in 
contradistinction to other TNP-coupled  cells, produced an immune  response that  
could not be suppressed by coadministrat ion of  an intravenous injection of  TNBS.  
Thus,  natural ly occurring specialized APC, as well as those induced by mycobacteria,  
activate effector cells that  are relatively resistant to suppression. 
Ma te r i a l s  a n d  M e t h o d s  
Animals. Inbred CBA/J mice of both sexes were obtained from The Jackson Laboratory 
(Bar Harbor, ME) at 6-8 wk of age and were rested 1 wk in an air-filtered enclosure before use. 
In any one experiment, mice were matched for both age and sex. 
Reagents. PCL (Eastman Organic Chemicals, Rochester, NY) was recrystallized three times 
from methanol before use, and was protected from light during storage. TNBS (Eastman 
Organic Chemicals) was used without further purification. A 10 mM TNBS stock solution was 
prepared so as to be isosomotic for cells (and, therefore, not to cause significant cell lysis) in the 
following way: 290 mg TNBS was dissolved in 70 ml phosphate-buffered saline (PBS). The pH 
of this solution was adjusted to 7.2 by the addition of 5 ml 0.5 M K2HPO4. To bring the final 
vol to 100 ml, 15 ml of double-distilled water was added, followed by 10 ml of PBS. The final 
osmolality was 310 mOsmol/liter. This solution was then filtered through a 0.45-p.m Millipore 
filter (Millipore Corp., Bedford, MA), and stored in 5-ml aliquots at -70°C. Freshly prepared 
TNBS was generally toxic for cells (>50% cells killed). After 2 wk in the freezer, toxicity was 
substantially reduced to 10-20%. 
Isolation of Splenic DC and Splenic Macrophages (Mdp). DC or M4~ were enriched from spleen 
adherent cells as described previously (7). Spleen adherent cells were cultured overnight, 
rosetted with antibody-coated erythrocytes, and separated into Fc- (DC enriched) and Fc + 
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chloride. The  cells in the DC-enriched fraction are >90% DC as assessed by cytologic criteria 
and absence of several Mq~ and lymphocyte surface markers (4, 7, 8). 
Induction of Peritoneal Exudates. PEC were harvested 5 d after intraperitoneal injection of 
various quantities of stimulators: (a) 0.5 ml H37LRa CFA or IFA (Difco Laboratories, Detroit, 
MI). Only the oil phase was injected, without emulsification with saline. (b) Bordetella pertussis 
vaccine (2 × 108 dead organisms) (Department of Public Health, Boston, MA). (c) 3 ml 
thioglycollate medium (Difco Laboratories). Cells were removed from the peritoneum after 
lavage with 5 ml Hanks'  balanced salt solution (HBSS) containing 5% fetal calf serum (Gibco 
Laboratories, Grand Island Biological Co., Grand IHand, NY). 
Hapten Labeling of Cells. Cells were suspended in PBS (pH 7.3) at a concentration of 108/ml 
before the addition of an equal volume of 10 m M  TNBS. Trinitrophenylation was carried out 
for 10 min at 37°C. Further hapten coupling was inhibited by the addition of HBSS containing 
10% fetal calf serum. Cells were washed three times with HBSS and viability, as assessed by 
trypan blue exclusion, was usually 80-90%. Total  cell recoveries after hapten coupling ranged 
between 70 and 90%. 
,Sensitization of PCL. Mice were sensitized by topical application of 0.1 ml of a 5% PCL 
solution in absolute ethanol to the shaved abdomen and four footpads. 
Induction of Unresponsiveness to PCL with TNBS. Specific unresponsiveness to PCL sensitization 
was induced by intravenous injection of 4 mg TNBS in 0.2 ml PBS. When hapten-coupled cells 
were administered at the same time, they were injected in the tail vein. Several minutes later, 
TNBS was injected into the retroorbital plexus. 
Induction of CS Immunity or Unresponsiveness by Cell-bound Hapten. C B A / J  mice were injected 
intravenously with varying numbers of hapten-conjugated cells in 0.2 ml HBSS. 7, 14, and 21 
d later, control ear thickness was measured with an engineer's micrometer (L. S. Starrett Co., 
Athol, MA) before application of 10-/tl doses of a 1% PCL solution (dissolved in olive oil) to 
each side of both ears. The  increment in ear thickness was then measured at various times after 
challenge. CS responses induced by hapten-conjugated cells, like CS induced by painting with 
PCL, were absent at 4 h, were evident by 18 h, persisted at 24 h, and by 48 h were decreased 
but still significant. 
Only CS responses 24 h after ear challenge of immunized groups are presented. In each 
experiment a separate group of nonimmune controls was challenged simultaneously with 1% 
PCL in olive oil and their resulting 24-h ear swelling responses, which varied from 2-10% 
increases, were subtracted from that of each immunized group to obtain the net percent 
increase, which was rounded off to the nearest integer. The statistical significance of the data 
was calculated using the two-tailed Student's t test with n - 2 degrees of freedom, where n = 
the number  of mice per experimental group. 
Adoptive Transfer of CS. Spleens and lymph nodes were removed from mice that were skin 
sensitized with PCL 7 d previously. Only spleens from mice immunized for the same length of 
time by intravenous injection of hapten-coupled cells were removed. Control ear thickness of 
the untreated C B A / J  recipients was measured before mice were injected intravenously with 5 
× 107 immune cells. Within l h of cell transfer, ears were painted with 1% PCL. The increment 
in ear thickness was measured 24 h after challenge. 
Estimation of the TNP Content of Coupled cells by 1z~I-MOPC 315 binding. 125I-labeled M O P C  
315 prepared as described by Zeldis et al. (9) was the kind gift of Dr. Robert  Rosenstein 
(Department of Pathology, Yale University School of Medicine, New Haven, CT). 5 × 106 
hapten-coupled cells were incubated with an excess of 125I-MOPC 315 (sp act - 1.8 × 10 ~ C i /  
mol) for 30 min at 4°C. Cells were washed extensively and transferred to clean tubes for 
counting. The  number  of counts bound permits comparison of the relative T N P  density on 
different cell types, provided they are about the same size and are labeled homogeneously. 
R e s u l t s  
Studies on CS Induced by Naturally Occurring Cells Coupled with TNP (Table I). Spleen  
a d h e r e n t  cells wer re  c u l t u r e d  ove rn igh t ,  d i s lodged  f rom the  surface,  a n d  sepa ra t ed  
in to  D C - r i c h  (Fc-)  a n d  Mth-rich (Fc +) f ract ions  by rose t t ing  w i t h  opson ized  e ry th ro-  
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Group 
TABLE I 
Induction of Long-lived CS by Intravenous Administration of 
TNP-coupled Splenic DC* 
TNP-coupled spleen ceils 
injected intravenously 
24-h net percent increase 
in ear swelling + SD:~ 
Type Number Day 7 Day 21 
A DC (3× 10 n) 1 1 + 3  1 0 + 2  
B DC (7 × 10') 4 :t: 1 12:1:0 
C Me (3 × 10 5) 0 0 
D M4~ (7 x 10 4) 0.5 :I: I ND§ 
* Results are from two separate experiments: one in which 4-6 mice per g r ~  
were tested on day 7, and the other in which four mice per group were tested 
on day 21. P <  0.05 for group A vs. C and D on day 7 and groups A and B 
vs. C on day 21. 
~: 24-h net percent increase ~ 24-h percent swelling response of immunized 
group that received TNP-coupled cells, minus 24-h percent swelling response 
of nonimmunized mice that were challenged simultaneously with 1% PCL. 
§ Not done. 
TASTE II 
Dominance of CS Induced by Hapten-coupled Splenic DC 
Over a Tolerogenic Dose of TNBS* 
Type of TNP- 
coupled spleen 
Group cells (3 × 10 r) Tolerogen 
injected intra- 
venously 
24-h net percent increase 
in ear swelling + SD:]: 
Day 7 Day 21 
A DC - -  1 9 + 3  19+ 1 
B DC TNBS 24 ::l: 5 23:1:3 
C M #  - -  21 + 6  0 + 4  
D M~ TNBS 0 + 2 4 ::t: 4 
* Table II shows the results of a single experiment in which each experimental 
group consisted of four mice. These animals were challenged at day 7 and 
then rechallenged at day 21. P < 0.05 for groups A, B, and C vs. D on day 
7 and groups A and B vs. C and D on day 21. 
:~ 24-h net percent increase = 24-h percent swelling response of immunized 
group that received TNP-coupled cells, minus 24-h percent swelling response 
of nonimmunized mice that were challenged simultaneously with 1% PCL. 
was  d e t e c t a b l e  a t  7 a n d  21 d a f t e r  i m m u n i z a t i o n .  In  c o n t r a s t  (in t he se  two  exper i -  
m e n t s ) ,  s i m i l a r  n u m b e r s  o f  T N P - c o n j u g a t e d  Mth fa i l ed  to i n d u c e  i m m u n i t y  to P C L  
a t  d a y  7 or  a t  d a y  21. T h u s ,  sp l en i c  DC,  l ike e p i d e r m a l  L a n g e r h a n s  cells (1), h a v e  a 
spec ia l  c a p a c i t y  to  p r e s e n t  a n t i g e n  a f t e r  i n t r a v e n o u s  i n j ec t i on ,  s u c h  t h a t  p e r s i s t e n t  C S  
ensues .  S p l e n i c  Mth, l ike P E C  i n d u c e d  b y  i n j e c t i o n  o f  oil  or  t h i o g l y c o l l a t e  (1), a r e  less 
w e l l - e q u i p p e d  to i n d u c e  th i s  t y p e  o f  p e r s i s t e n t  response .  
Immunity Induced by TNP-DC: Effect of Coimmunization with a Tolerogenic Dose of TNBS 
(Table II). A l t h o u g h  T N P - c o u p l e d  sp l en i c  Mqb fa i led  to i n d u c e  C S  a f t e r  i n t r a v e n o u s  
i n j e c t i o n  in  t h e  e x p e r i m e n t s  p r e s e n t e d  in  T a b l e  I, t h i s  was  n o t  a l w a y s  t h e  case.  
O c c a s i o n a l l y ,  t hese  cells i n d u c e  CS.  Because  p r e v i o u s  w o r k  s u g g e s t e d  t h a t  al l  I a  ÷ 
g l a s s - a d h e r e n t  cells c o u l d  p r e s e n t  a n t i g e n  e f fec t ive ly  i f  s u p p r e s s o r  m e c h a n i s m s  were  
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TABLE III 
Induction of CS to PCL by TNP-coupled PEC Induced by Various Activators* 
Group PEC stimulator 
24-h net percent increase 
in ear swelling + SD:I: 
Day 7 Day 14 
A None§ - 1 +-- 2 ND 
B IFA 5 ± 2 2 ± 5 
C B. pertussis vaccine 2 ± 1 ND]] 
D Thioglycollate medium I ± 5 0 ± 6 
E CFA 15 ± 3 i3 ± 2 
* Mice were injected intravenously with 5 × 106 TNP-PEC and 7 or 14 d later 
their ears were challenged with 1% PCL. The data were compiled from four 
independent experiments in which each experimental group consisted of four 
to five animals. Each regimen was tested at least twice. P < 0.05 for groups 
A, BT"U, and D vs. E on day 7 and groups B and D vs. E on day 14. 
:~ 24-h net percent increase ffi 24-h percent swelling response of immunized 
group that received TNP-coupled cells, minus 24-h percent swelling response 
of nonimmunized mice that were challenged simultaneously with 1% PCL. 
§ Unstimulated peritoneal cells. 
[I Not done. 
spleen cells induce i m m u n i t y  after intravenous injection, they do so by avoiding 
suppression. To  test this notion, we performed several experiments in which we 
immunized  mice intravenously with TNP-labeled  cells and  at the same time gave 
them a tolerogenic dose of TNBS. The  results in Tab le  II show that on those occasions 
when CS is induced by TNP-coupled  splenic Mq~, the response is different from that 
induced by T N P - D C  in two ways: (a) it is completely suppressed by concommi tan t  
injection of TNBS and  (b) it vanishes by day 21, even when no other tolerogenic 
st imulus is presented. Most likely, the waning  of the response is because of its 
sensitivity to regulatory suppressive mechanisms. Thus,  our results show in two 
different ways that  the i m m u n e  response induced by T N P - D C  is more resistant to 
suppression than  is the response induced by TNP-Mq~. Futhermore,  the failure of 
TNBS injection to diminish the response in mice immunized  with T N P - D C  indicates 
that these cells induce a truly suppressor-resistant response, not that they simply fail 
to activate suppression. 
Studies of CS Induced by TNP-coupled PEC Induced by Mycobacteria (Table IH). 
Int ravenous  injection of T N P  bound  to resident peritoneal cells or PEC st imulated by 
IFA, B. pertussis vaccine, or thioglycollate med ium failed to induce detectable CS to 
PCL at day 7 or day 14 after immuniza t ion .  In addit ion,  subsequent  at tempts  to 
sensitize these nonresponding  mice by skin pa in t ing  with PCL ~24 h after pr imary  
challenge also failed to induce CS (data not shown). Thus,  TNP-conjuga ted  PEC 
that were elicited by these means failed to induce i m m u n i t y  and  appeared to induce 
unresponsiveness when injected intravenously.  In contrast, T N P  conjugat ion of PEC 
st imulated by CFA (containing heat-killed H 37Ra  mycobacteria) induced CS that 
was elicited at day 7 and  still elicitable at day 14 after intravenous immuniza t ion .  
Thus,  TNP-conjuga ted  PEC st imulated by mycobacteria  (TNP-CFA-PEC)  not only 
failed to induce unresponsiveness to PCL but  had acquired the capacity to induce 
i m m u n i t y  to PCL when administered by the intravenous route. Furthermore,  like CS 
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gated epidermal  Langerhans  cells (1) or splenic DC (Tables I and  II), CS induced by 
T N P - C F A - P E C  was relatively long-lived. 
Effect of Varying Cell Numbers on the Induction of CS with TNP-conjugated Cells (Table 
IV). In t ravenous  injection of 5 × 107 haptena ted  spleen cells is a s tandard  protocol 
for the induct ion  of unresponsiveness to CS (3), whereas only 5 × 106 T N P - C F A - P E C  
given intravenously was needed to immunize  mice for CS. To determine whether  this 
qual i ta t ive difference was a function of cell n u m b e r  a n d / o r  dose of ant igen,  varying 
numbers  of TNP-conjuga ted  PEC or spleen cells were injected intravenously into 
mice that  were challenged at day 14. T N P - C F A - P E C  were capable of induc ing  CS at 
doses of 5 × 107 or 5 × 106 cells but  not at a dose of 5 × 105 cells. Hapten-conjuga ted  
IFA-PEC or spleen cells, however, failed to induce CS at all doses tested. Thus,  the 
immun iz ing  potential  of T N P - C F A - P E C  remained intact  at higher numbers  of cells 
and  disappeared when too few cells were injected. Neither increasing nor decreasing 
the dose of hapten-conjugated  IFA-PEC or spleen cells gave them the capacity to 
induce i m m u n i t y  by int ravenous injection. These results strongly suggest that  quali-  
tative and  not simple quant i ta t ive  differences account for the difference in i m m u n i z i n g  
capacity of the two cell types. 
Estimation of Relative TNP Content of Hapten-conjugated Cells (Table V). The data  in 
Tab le  IV are consistent with the idea that  induct ion of CS with T N P - C F A - P E C  is 
not a result of a cellular dose effect. The  total amoun t  of T N P  injected, however, may 
be a crucial de te rminan t  of immunogenici ty .  Thus,  it was impor tan t  to quan t i t a te  
the n u m b e r  of haptenic  de terminants  that were injected into the mice. To  address 
this question, equal  numbers  of hap tena ted  or nonhap tena t ed  cells were incuba ted  
with an excess of 125I-MOPC-315, a T N P - b i n d i n g  myeloma protein, for 30 min  at 
4°C. After extensive washing, cells were transferred to new tubes for counting.  The  
results (Table V) allow comparison of the average n u m b e r  of counts bound  by spleen 
TABLE IV 
Induction of CS to PCL by TNP-coupled Cells: Dose Response* 
Group Cells injected intravenously 
24-h net percent 
increase in ear 
swelling ± SD on 
day 14~ 
A 5 × 107 TNP-CFA-PEC 21 ± 5 
B 5 × 106 TNP-CFA-PEC 20 ± 3 
C 5 × 105 TNP-CFA-PEC 6 ± 3 
D 5 × 107 TNP-IFA-PEC 0 ± 0 
E 5 × 106 TNP-IFA-PEC 3 ± 4 
F 5 X 105 TNP-IFA-PEC 4 ± 4 
G 5 × 10 7 TNP-spleen cells 0 +__ 4 
H 5 X 10 6 TNP-spleen cells 3 ± 2 
I 5 × 10 5 TNP-spleen cells 4 ± 3 
* Table IV shows the results of a single experiment in which each experimental 
group consisted of four animals. P < 0.05 for groups A and B vs. C, D, E, F, 
G, H, and I. 
:~ 24-h net percent increase = 24-h percent swelling response of immunized 
group that received TNP-coupled cells, minus 24-h percent swelling response 
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TABLE V 
Binding of l2SI-MOPC 315 to Haptenated vs. Nonhaptenated Cells* 
Counts per 
Hapten minute 
Group Cell type coating bound 
A CFA-PEC TNP 2,780 
B CFA-PEC None 215 
C IFA-PEC TNP 2,686 
D IFA-PEC None 62 
E Thioglycollate-PEC TNP 12,515 
F Thioglycollate-PEC None 746 
G Spleen cells TNP 7,046 
H Spleen cells None 451 
I None None 514 
* 5 × 10 e haptenated or nonhaptenated cells were incubated with an excess of 
a~SI-MOPC-315 (sp act ~ 1.8 x 10 n Ci/mol) for 30 min on ice, Results are 
the average of triplicate tubes. 
TABLE VI 
Failure of Nonhaptenated CFA-PEC to Provide an Adjuvant Effect 
for TNP Presented on IFA-PEC* 
Group Cells injected intravenously 
24-h net per- 
cent increase in 
ear swelling + 
SD at day 21~: 
A 5 × 10 e TNP-CFA-PEC 15 :i: 4 
B 5 x 10 6 TNP-IFA-PEC 2 _+ 3 
C 5 × 10 e TNP-IFA-PEC + 5 × 10 6 3 +- 3 
CFA-PEC 
* Ceils were mixed and injected in a vol of 0.4 ml HBSS via the tail vein. Each 
experimental group consisted of four mice. P < 0.05 for group A vs. B and 
C. 
~: 24-h net percent increase = 24 h percent swelling response of immunized 
group that received TNP-coupled cells, minus 24-h percent swelling response 
of nonimmunized mice that were challenged simultaneously with i% PCL. 
cells or  P E C  s t i m u l a t e d  b y  C F A ,  IFA,  or  t h i o g l y c o l l a t e  m e d i u m .  A l t h o u g h  sp l een  
cells a n d  t h i o g l y c o l l a t e - s t i m u l a t e d  P E C  b o u n d  2 - 5  t i m e s  m o r e  c o u n t s  t h a n  P E C  
s t i m u l a t e d  b y  C F A  or  IFA,  it was  c l ea r  t h a t  b i n d i n g  o f  M O P C - 3 1 5  to C F A  or  IFA-  
P E C  was  e q u i v a l e n t .  S i n c e  C F A  a n d  I F A - P E C  were  r o u g h l y  s i m i l a r  in  size, as 
d e t e r m i n e d  b y  m i c r o s c o p i c  i n spec t ions ,  t h e  d i f f e rences  in  i m m u n i z i n g  p o t e n t i a l  
b e t w e e n  the se  cells c a n n o t  b e  a c c o u n t e d  for  s i m p l y  o n  t h e  bas is  o f  a n t i g e n  ( h a p t e n )  
dose. 
Requirement for Haptenation of the CFA-stimulated PEC for Antzgen Presentation (Table 
I11). T o  d e t e r m i n e  w h e t h e r  t h e  d i f f e rences  in  i m m u n i t y  i n d u c e d  b y  h a p t e n - c o n j u -  
g a t e d  C F A  a n d  I F A - P E C  were  a c t u a l l y  r e l a t e d  to a n t i g e n  p r e s e n t a t i o n  b y  these  cells 
or  resu l t  f r o m  a n  i l l -de f ined  a d j u v a n t  effect  o f  t he  m y c o b a c t e r i a  o n  b y s t a n d e r  cells, 
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TABLE V I I  
Dominance of CS Induced by TNP-CFA-PEC: 
Effect of Coimmunization with TNBS 
1351 
24-h net per- 
Group cent increase 
(4 mice/ Immunogen* Tolerogen~: in ear swelling 
group) ± SD at 
day 7§ 
A TNP-CFA-PEC - -  15 ± 6 
B TNP-CFA-PEC TNBS 21 ± 4 
C TNP-IFA-PEC - -  7 ± l 
D TNP-IFA-PEC TNBS 2 ± 1 
E 5% PCL topically - -  27 ± 3 
F 5% PCL topically TNBS[] 4 ± 4 
* 5 × 106 TNP-coupled cells were injected intravenously via the tail vein. 
1: Several minutes after injection of cells, 4 mg TNBS was injected into the 
retroorhital venous plexus. 
§ Each experimental group consisted of four to five mice. P < 0.05 for groups 
A, B, and C vs. D. 24-h net percent increase -- 24-h percent swelling response 
of immunized group that received TNP-coupled cells or PCL topically, 
minus 24-h percent swelling response of nonimmunized mice that were 
challenged simultaneously with 1% PCL. 
]] 4 mg TNBS was injected intravenously 7 d before topical application of 5% 
PCL. 
TABLE V I I I  
Adoptive Transfer of CS to PCL Induced by TNP-CFA-PEC 
or TNP-IFA-PEC* 
Group Immunization 
24-h net percent increase 
in ear swelling ± SD at 
day 7~ 
Donor Recipient 
A 5% PCL 30 ± 6 15 ± 5 
B TNP-CFA-PEC (5 x 10s)§ 16 ± 3 7 ± 2 
C TNP-IFA-PEC (5 × 106) 10 ± 1 0 ± 3 
CS at day 14 
Donor Recipient 
D 5% PCL 3I ± 5 ll :t: 5 
E TNP-CFA-PEC (5 × 106) 23 ± 1 13 + 6 
F TNP-IFA-PEC (5 × 106) 0 ± 5 0 + 3 
* Table VlIl  shows data combined from three independent experiments in 
which donor experimental groups consisted of four animals, and recipient 
experimental groups consisted of six animals. P <  0.05 for groups A, B, C, D, 
and E vs. F (donors) and P < 0.05 for groups A and B vs. C and groups D 
and E vs. F (recipients). 
~: 24-h net percent increase ~ 24-h percent swelling response of immunized 
groups that were actively sensitized or received immune cells, minus 24-h 
percent swelling response of nonimmunized mice that were challenged 
simultaneously with 1% PCL. 
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antigen presentation. The results in Table VI show that the inability to induce 
persistent immunity with TNP-IFA-PEC cannot be overcome by coadministration of 
nonhaptenated CFA-stimulated PEC. 
Effect of Coimrnunization with TNP-PEC and a Tolerogenic Dose of TNBS (Table 
VII). Although TNP-IFA-PEC failed to induce CS after intravenous injection in 
the experiments presented in Tables III, IV, and VI, on some occasions these cells 
(like splenic M ~  [Table II]) can induce CS. Thus we performed a series of experiments 
in which we coadministered a tolerogenic dose of TNBS to test whether CS induced 
by TNP-IFA-PEC was more sensitive to suppression than that induced by TNP-CFA- 
PEC. Intravenous injection of 4 mg TNBS 7 d before a sensitizing skin-painting with 
PCL blocked the induction of CS to PCL (groups E and F). Nonetheless, when TNP-  
CFA-PEC were injected into mice simultaneously with this dose of TNBS, CS at day 
7 was undiminished when compared with mice immunized with TNP-CFA-PEC 
alone (groups A and B). In this experiment, hapten-conjugated IFA-PEC were very 
weakly immunogenic, in contrast to earlier experiments in which they failed to induce 
CS by the intravenous route. However, coadministration of TNBS prevented the 
development of  this CS. Thus, although both IFA- and CFA-stimulated PEC provided 
effective antigen presentation, CS induced by TNP-CFA-PEC was not only quanti- 
tatively greater, but was also insensitive to suppression by coadministration of TNBS. 
The Ability to Adoptively Transfer CS Induced by Hapten-conjugated CFA vs. IFA-PEC 
(Table VIII). Since the initial demonstrations by Dresser (10) and Celada (11) it has 
been shown repeatedly that some immune responses are hard to adoptively transfer 
without inactivating the recipient's suppressor T cells (12). Thus, we reasoned that if 
the effector cells of CS that arise after immunization with TNP-CFA-PEC are truly 
suppressor resistant, then they should be better able to transfer CS than effector cells 
that are raised by immunization with TNP-IFA-PEC. The results shown in Table 
VII I  demonstrate that the CS elicited at both day 7 and 14 in mice topically sensitized 
with PCL could be adoptively transferred into normal recipients. The magnitude of 
the ear swelling response induced by TNP-CFA-PEC was less than that obtained by 
skin painting, but the efficiency of transfer was at least as good. In contrast, TNP-  
IFA-PEC induced a moderate level of CS at day 7 that was no longer detectable by 
day 14. Furthermore, day-7 CS that was induced by TNP-IFA-PEC was more 
sensitive to suppressor mechanisms that prevent cell transfer of CS than were T cells 
induced by TNP-CFA-PEC. 
Discussion 
The results we have presented in this manuscript taken together with previous 
results (1) suggest that the type of cell that presents antigen to the immune system is 
of great importance in determining both the qualitative and quantitative aspects of 
the immune response that an antigen will stimulate. We have identified two major 
classes of APC that can be distinguished from one another by the sensitivity to 
suppression of the immune response they induce. 
Previous studies have shown that TNP-labeled Ia + PEC can induce evanescent CS 
if injected subcutaneously. However, induction of CS by administration of these cells 
by the intravenous route requires pretreatment of the host with cyclophosphamide 
(1). On the other hand, TNP-labeled epidermal Langerhans cells injected by either 
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antigen intravenously did not depend upon avoidance of suppressor cell induction in 
the spleen (accomplished by subcutaneous injection) or elimination of suppressor cells 
by cyclophosphamide (13), but was a result of their induction of suppressor-resistant 
effector cells (1). 
We have now shown that another naturally occurring APC type, i.e., splenic DC, 
can act like Langerhans cells and that this specialized capacity to present antigen can 
also be induced in peritoneal exudates by mycobacteria. We have further emphasized 
the T suppressor resistance of the CS response induced by DC- or CFA-induced PEC 
by showing that the immune response that occurs after they present TNP to the 
system is: (a) long lived, (b) not affected by coadministration intravenously of a highly 
tolerogenic dose of TNBS, and (c) can be adoptively transferred to antigenically naive 
recipients. This last point is particularly helpful in determining the mechanism by 
which these specialized APC work because of the recent findings of Iverson et al. 2, 
who showed that adoptive transfer of CS to normal recipients required a cell that 
could protect T effector cells from the action of host suppressor T cells that are 
activated by the adoptively transferred cells. These protector cells can be distinguished 
from other T cells by their expression of a unique cell surface antigen coded for by 
genes in the I-J subregion of the major histocompatibility complex and have been 
referred to as contrasuppressor cells (14). Adoptive immunity does not require the 
presence of these contrasuppressor cells when the recipient's suppressor system has 
been diminished by treatment with low doses of cyclophosphamide. 
All three of the distinctive features of the CS response induced by the specialized 
APC we have tested can be explained by the induction of a response that is relatively 
resistant to normal suppressor mechanisms. The results of the adoptive transfer 
experiments indicate that the resistance to suppression is mediated, at least in part, 
by contrasuppressor cells. Taken together then, our results suggest that specialized 
APC not only activate helper and/or  effector T cells, but that they also activate the 
cells that comprise the contrasuppressor circuit (14, 15). 2 
The question of how these specialized APC induce suppressor-resistant effector cells 
and/or  activate contrasuppressor cells remains to be determined. The amount of Ia 
antigen that APC express on their surface or the rate at which they shed these antigens 
into the local environment may influence the type of T cell subset with which they 
interact. Thus, some T cell subsets may have to recognize more self-major histocom- 
patibility complex-encoded antigen on the APC to be activated. Alternatively--or 
additionally--specialized APC may present, in addition to antigen, other signals that 
activate special T cell gene programs, including the one that makes T cells resistant 
to suppression. This could be accomplished by modulating the numbers of receptors 
that T cells express for suppressor factors. Mechanisms involving Ia antigens are 
particularly attractive because: (a) intensive immunization with mycobacterial adju- 
vants induces increased numbers of Ia ÷ macrophages (5), (b) splenic DC express large 
amounts of Ia (4, 7), and (c) agents that inhibit turnover of Ia on cell surfaces diminish 
the ability of the treated cells to stimulate immune responses. ~ However, Ia positivity 
per se cannot explain our results. Ia + thioglycollate-induced TNP-PEC are needed to 
2 Iverson, G. M., W. Ptak, D. R. Green, and R. K. Gershon. The role of contrasuppression in the adoptive 
transfer of immunity. Manuscript submitted for publication. 
n Emerson, S. G. J. Pretell, W. Stock, G. M. Iverson, D. Murphy, and R. K. Gershon. Treatments which 
influence the expression and shedding of [a antigens inhibit the ability of cells to stimulate mixed 
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induce even the short-lived form of CS, and treatment with anti-Ia and complement 
eliminates this. Furthermore, when these same Ia + cells are injected intravenously, 
they induce tolerance (1). Finally, the day-4 IFA- and CFA-PEC that induce the two 
types of CS do not grossly differ in numbers of Ia + cells (-5%), as judged by indirect 
immunofluorescence in two separate experiments (our unpublished observations). 
Another possibility that must be considered stems from the finding that splenic DC 
express high levels of H-2D as well as I-A (4). Because cells in suppressor circuit 
appear to be preferentially activated by allogeneic H-2D (16), it would not be at all 
surprising if contrasuppressor cells also had a predilection for reacting with antigen in 
association with H-2D. Thus, the reason that DC are such exceptionally good APC 
may be a result of their high levels of Ia, which help them activate helper cells, and 
also of their high levels of H-2D, which help them present signals to the contrasup- 
pressor system. 
In the search for variables that might be important in explaining the differential 
ability of hapten-labeled CFA vs. IFA-activated PEC to induce persistent CS reac- 
tions, the numbers of APC inoculated and quantitation of the number  of haptenic 
groups per APC were examined. These factors, however, were not able to account for 
the observed differences. CFA may cause an influx of DC into the peritoneal cavity, 
which has been identified in bacillus Calmette-Gufirin-elicited exudates (17), and 
some of the adjuvant properties of  CFA may be attributed to the inducibility of this 
APC population. However, we should also emphasize that although TNP-labeled DC 
and TNP-CFA-PEC both have similar effects on the immune system, the mechanism 
by which they work need not be precisely the same. 
In sum, the results we have presented indicate that one of the important variables 
in determining the type of an immune response that an antigen will induce depends 
on the type of cell that presents the antigen to the regulatory T cell system. When 
some specialized APC present the antigen, then the immune response will be, if not 
quantitatively stronger, certainly longer-lasting and harder to suppress. These attri- 
butes could be responsible for important qualitative changes that occur during the 
course of an immune response such as the production of high affinity antibodies that 
take a long time to be generated and that, being highly sensitive to T cell-suppressor 
mechanisms (18, 19), must be protected during the maturation and/or  differentiation 
of precursor cells. 
S u m m a r y  
We have tested the ability of several types of trinitrophenyl (TNP)-labeled Ia + cells 
to induce contact hypersensitivity (CS) after intravenous injection. Most labeled cell 
types (spleen cells, splenic macrophages, various types of peritoneal°exudate cells) not 
only fail to induce CS after this type of inoculation but, rather, activate T suppressor 
cells leading to specific immunological tolerance. Occasionally, some of these immu- 
nizing cells managed to bypass the T suppressor system and induced CS. In those 
cases the response was short-lived and could be blocked by concomitant injection of 
trinitrobenzelsulphonic acid (TNBS), a potent inducer of T suppressor cells. 
In sharp contrast to these results, TNP-labeled splenic dendritic cells and TNP-  
labeled peritoneal-exudate cells induced by complete Freund's adjuvant had the 
following distinctive features: (a) They were always able to sensitize when injected 
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to tha t  achieved by  cutaneous  app l i ca t ion  o f  picryl  chloride,  the  chemica l ly  react ive 
form of  TNP .  (b) T h e  response they el ici ted was long lived (i.e., lasted for > 3  wk). 
(c) The i r  sensit izing capac i ty  could not  be blocked by  the concomi tan t  inject ion of  
TNBS.  (d) T h e y  el ici ted a response that  could be adop t ive ly  t ransferred to un t rea ted ,  
normal  recipients.  
These  results indicate  tha t  the  type  of  cell tha t  first presents an t igen  to the i m m u n e  
system plays an  impor tan t ,  even essential,  role in de te rmin ing  the s t rength  and  
du ra t ion  of  the subsequent  i m m u n e  response. In par t icu la r ,  the results suggest that  
some special an t igen-present ing  cells can induce a response that  is re la t ively resistant  
to host suppressor  mechanisms.  Evidence tha t  they  do so by  ac t iva t ing  cont rasup-  
pressor cells is discussed. 
Received for publication 23 September 1981 and in revised form 2 February 1982. 
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